Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 5, 2012 - Issue
Submit an article Journal homepage
57
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects

Shailendra KapoorMechanicsville, Richmond, VA, USACorrespondence[email protected]
Pages 121-123 | Published online: 11 May 2012

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Daniel Q Holland & Joshua J Neumiller. (2014) Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity 7, pages 277-288.
Read now
Annalisa Capuano, Liberata Sportiello, Maria Ida Maiorino, Francesco Rossi, Dario Giugliano & Katherine Esposito. (2013) Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy – focus on alogliptin. Drug Design, Development and Therapy 7, pages 989-1001.
Read now

Articles from other publishers (1)

Eiji Kutoh & Hiroshi Yamashita. (2012) Differential effects on metabolic parameters between sitagliptin and alogliptin in drug naïve subjects with type 2 diabetes. Journal of Diabetes Research and Clinical Metabolism 1:1, pages 17.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.